The authors are indebted to Kim Shepard, John Winters, Amanda Green, and Colleen Lentz for technical assistance and data analysis
Semaglutide may be a suitable option for individuals who have struggled to achieve weight loss through diet and exercise alone and have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity, such as hypertension or type 2 diabetes
"Submaximal performance testing" is a way of measuring or estimating aerobic fitness in sports medicine
On average, participants lost 10 to 20% of their initial body weight over several months
Lee, P., Danish, R., Mazur, T